{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:25:39Z","timestamp":1792099539179,"version":"4.4.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>\n                      Donation after circulatory death (DCD) or hepatitis C virus (HCV\n                      <jats:sup>+<\/jats:sup>\n                      ) liver grafts are underused among transplant centers in the United States. The study aimed to evaluate organ utilization and outcomes of liver grafts from DCD donors with HCV infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>\n                      National registry and local center data of all deceased donor liver transplants performed between November 2016 and December 2021 were analyzed. All transplants were divided into 4 groups: HCV\n                      <jats:sup>\u2013<\/jats:sup>\n                      DCD, HCV\n                      <jats:sup>\u2013<\/jats:sup>\n                      donation after brain death [DBD], HCV\n                      <jats:sup>+<\/jats:sup>\n                      DCD, and HCV\n                      <jats:sup>+<\/jats:sup>\n                      DBD. The outcome of interest was 1-y graft survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Out of 146 liver transplant centers in the United States, liver transplants were not performed from DCD donors, HCV\n                      <jats:sup>+<\/jats:sup>\n                      donors, and a combination of DCD and HCV\n                      <jats:sup>+<\/jats:sup>\n                      donors by 28.7%, 27%, and 70%\u201372% of centers, respectively. In multivariate analysis, increasing center acceptance ratio was associated with increased utilization of liver grafts from DCD HCV\n                      <jats:sup>\u2013<\/jats:sup>\n                      and DCD HCV antibody-positive nucleic acid test negative donors. Nationally, 1-y graft survival of HCV\n                      <jats:sup>\u2013<\/jats:sup>\n                      DCD liver grafts was lower compared with other groups (89% versus 92% HCV\n                      <jats:sup>+<\/jats:sup>\n                      DCD versus 93% HCV\n                      <jats:sup>+<\/jats:sup>\n                      DBD versus 92% HCV\n                      <jats:sup>\u2013<\/jats:sup>\n                      DBD, log rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.0001). There was no difference in 1-y graft survival among groups locally.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>\n                      Liver grafts from HCV\n                      <jats:sup>+<\/jats:sup>\n                      DCD donors have 1-y patient and graft survival comparable with DBD liver grafts from donors with or without HCV infection. These results encourage the widespread use of liver grafts from DCD and HCV\n                      <jats:sup>+<\/jats:sup>\n                      donors and standardization of practice in DCD donation to expand the donor pool without compromising short-term outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005174","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T21:39:44Z","timestamp":1724362784000},"page":"186-195","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Outcomes of Liver Transplantation From Hepatitis C Virus\u2013positive DCD Donors and Its Utilization Among Centers in the United States"],"prefix":"10.1097","volume":"109","author":[{"given":"Sai Rithin","family":"Punjala","sequence":"first","affiliation":[{"name":"Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April J.","family":"Logan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanthan","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Von Stein","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Limkemann","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musab","family":"Al-Ebrahim","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvester","family":"Black","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin D.","family":"Schenk","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.","family":"Washburn","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"2 Suppl 1","key":"R1-20241224","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","article-title":"OPTN\/SRTR 2021 annual data report: liver.","volume":"23","author":"Kwong","year":"2023","journal-title":"Am J Transplant"},{"key":"R2-20241224","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cld.222","article-title":"Expanding the donor pool in liver transplantation: extended criteria donors.","volume":"2","author":"DeLemos","year":"2013","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R3-20241224","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12876-016-0551-z","article-title":"Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor.","volume":"16","author":"Stepanova","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"R4-20241224","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11605-022-05313-0","article-title":"Safely expanding the liver donor pool by utilization of organs from donation after circulatory death with comparable results to donation after brain death, a large single-center experience.","volume":"26","author":"Limkemann","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"R5-20241224","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ajt.13976","article-title":"Changes in utilization and discard of hepatitis C-infected donor livers in the recent era.","volume":"17","author":"Bowring","year":"2017","journal-title":"Am J Transplant"},{"key":"R6-20241224","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index.","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"R7-20241224","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting.","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R8-20241224","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.32208","article-title":"Banff consensus recommendations for steatosis assessment in donor livers.","volume":"75","author":"Neil","year":"2022","journal-title":"Hepatology"},{"key":"R9-20241224","doi-asserted-by":"crossref","first-page":"e2335715","DOI":"10.1001\/jamanetworkopen.2023.35715","article-title":"Alcohol use and sustained virologic response to hepatitis C virus direct-acting antiviral therapy.","volume":"6","author":"Cartwright","year":"2023","journal-title":"JAMA Network Open"},{"key":"R10-20241224","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/lt.25424","article-title":"Improved graft survival after liver transplantation for recipients with hepatitis C virus in the direct-acting antiviral era.","volume":"25","author":"Cotter","year":"2019","journal-title":"Liver Transpl"},{"key":"R11-20241224","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.ajkd.2022.12.019","article-title":"Kidney transplantation from hepatitis C virus\u2013infected donors to uninfected recipients: a systematic review for the KDIGO 2022 hepatitis C clinical practice guideline update.","volume":"82","author":"Gordon","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"R12-20241224","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients.","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"R13-20241224","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.15162","article-title":"Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.","volume":"19","author":"Kwong","year":"2019","journal-title":"Am J Transplant"},{"key":"R14-20241224","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1097\/TP.0000000000001483","article-title":"Improving national results in liver transplantation using grafts from donation after cardiac death donors.","volume":"100","author":"Croome","year":"2016","journal-title":"Transplantation"},{"key":"R15-20241224","doi-asserted-by":"crossref","first-page":"e1650","DOI":"10.1097\/TXD.0000000000001650","article-title":"Variation in DCD liver transplant protocols among transplant centers in the United States.","volume":"10","author":"Punjala","year":"2024","journal-title":"Transplant Direct"},{"key":"R16-20241224","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamasurg.2021.6781","article-title":"Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT Randomized Clinical Trial.","volume":"157","author":"Markmann","year":"2022","journal-title":"JAMA Surg"},{"key":"R17-20241224","doi-asserted-by":"crossref","first-page":"e14659","DOI":"10.1111\/ctr.14659","article-title":"Early United States experience with liver donation after circulatory determination of death using thoraco-abdominal normothermic regional perfusion: a multi-institutional observational study.","volume":"36","author":"Sellers","year":"2022","journal-title":"Clin Transplant"},{"key":"R18-20241224","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/lt.23396","article-title":"Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.","volume":"18","author":"Lai","year":"2012","journal-title":"Liver Transpl"},{"key":"R19-20241224","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jhep.2017.10.034","article-title":"The UK DCD Risk Score: a new proposal to define futility in donation-after-circulatory-death liver transplantation.","volume":"68","author":"Schlegel","year":"2018","journal-title":"J Hepatol"},{"key":"R20-20241224","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/TP.0000000000004401","article-title":"DCD Hepatitis C virus\u2013positive donor livers can achieve favorable outcomes with liver transplantation and are underutilized.","volume":"107","author":"Myers","year":"2023","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T07:00:43Z","timestamp":1735023643000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005174","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}